“We believe we are launching a new cancer therapy field here,” says Jamey Weichert, professor of radiology. “It’s very exciting, and the research team is incredible.”
A gene that cured a man of HIV a decade ago has been successfully added to developing monkey embryos in an effort to study more potential treatments for the disease.
A study shows that the mutant virus is more easily transmitted and grows better within hosts, likely aiding its dominance. The mutation, researchers say, should not interfere with the effectiveness of vaccines against the virus.
Neither of the new viruses is known to infect people, but the findings reinforce the important work scientists are undertaking to study the effects of a changing environment on human and animal diseases.
UW neuroscientists led by Su-Chun Zhang found that neurons derived from stem cells can connect with native neurons and restore motor functions. But more research is needed to translate the findings from mice to people.
Researchers believe the same approach can be applied to several other respiratory pathogens, including the novel coronavirus that causes COVID-19.
Leaders and staff at UW–Madison, including people who care for and provide oversight of our animals, take seriously our responsibility to care for animals in research.
The trials center around an “antibody cocktail” called REGN-COV2, which was created by the New York-based pharmaceutical company Regeneron.
UW–Madison researchers have developed a safer and more efficient way to deliver a promising new method for treating cancer and liver disorders and for vaccination — including a COVID-19 vaccine that has advanced to clinical trials.
The animals are useful to researchers trying to understand SARS-CoV-2 and in the evaluation of vaccines, treatments and drugs against the disease it causes.